The ACCeRT Study - Auckland’s Cancer Cachexia evaluating Resistance Training Study: A randomised feasibility study of EPA and Cox-2 inhibitor (Celecoxib) versus EPA, Cox-2 inhibitor (Celecoxib), Progressive Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic participants

ResearchSpace/Manakin Repository

Full text options

This item appears in the following Collection(s)


Search ResearchSpace

Advanced Search